Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629052 · ClinicalTrials.gov registry record
TrEatment Approach in the Multimodal Era Registry
A clinical trial of Chronic Thromboembolic Pulmonary Hypertension and CTEPH, sponsored by International CTEPH Association.
- Active
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT05629052 is a study of Chronic Thromboembolic Pulmonary Hypertension and CTEPH that is active but no longer recruiting, run by International CTEPH Association. The registered enrollment target is 1,000 participants, above the 617-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (62% higher). The trial reports 20 study locations across 6 states.
The verdict
NCT05629052, a study of Chronic Thromboembolic Pulmonary Hypertension and CTEPH, is active but no longer recruiting, sponsored by International CTEPH Association.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this observational patient registry is to learn how expert centers treat patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition in which blood clots block the blood vessels in the lungs. There are currently three treatment options for patients with CTEPH: * surgery to remove blood clots from large vessels in the lungs (pulmonary endarterectomy (PEA)) * the use of a small balloon to unblock smaller blood vessels (balloon pulmonary angioplasty (BPA)) * drugs Patients can also receive a combination of these treatments. The main question this registry aims to answer are: * How many patients receive a given kind of treatment? * How do expert centers combine the different treatments? * Are patients doing better after they receive a given kind of treatment? * How many patients are alive 1, 3 and 5 years after they receive a given kind of treatment? Participants will receive the same treatments that they would receive if they did not participate in the study. During the study, patients will visit their doctors as they would do normally. The doctors will collect information on the patients' health and enter it into the study database. The follow-up time will be at least 3 years for all patients.
Conditions Studied
Interventions
- PROCEDURE Pulmonary endarterectomy
- PROCEDURE Balloon pulmonary angioplasty
- DRUG Pulmonary hypertension (PH)-specific medication
Study Locations (20)
Other
- Hospital Universitario Fundación Favaloro - Buenos Aires
- University Hospital Vienna - Vienna
- University Hospitals Leuven - Leuven
- Santa Casa - Porto Alegre
- China-Japan Friendship Hospital - Beijing
- Shaio Clinic Foundation - Bogotá
- General University Hospital - Prague
- Aarhus University Hospital - Aarhus
- Kerckhoff Clinic, Department of Thoracic Surgery - Bad Nauheim
- Narayana Institute of Cardiac Science - Bangalore
- University of Bologna - Bologna
- Okayama Medical Center - Okayama
- National Cerebral and Cardiovascular Center - Osaka
- National Heart Institute - Mexico City
- Department of Cardiac and Vascular Diseases, John Paul II Hospital - Krakow
California
- University of California San Diego - San Diego
Illinois
- Northwestern University - Evanston
North Carolina
- Duke University - Durham
Texas
- UT Southwestern - Dallas
Ontario
- Toronto General Hospital - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-04-12 |
| Est. Completion | 2028-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05629052
The ClinicalTrials.gov registry entry for NCT05629052 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 617-participant average among 6 other Chronic Thromboembolic Pulmonary Hypertension trials with a reported enrollment target (62% higher). The listed sponsor is International CTEPH Association, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Thromboembolic Pulmonary Hypertension appearing as the primary indexed condition, and to 3 interventions - of which Pulmonary endarterectomy is the first listed.
NCT05629052 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Other, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT05629052 about?
NCT05629052 is a clinical study titled "TrEatment Approach in the Multimodal Era Registry". The goal of this observational patient registry is to learn how expert centers treat patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition in which blood clots block the blood vessels in the lungs. There are currently three treatment options for patients with CTEP...
What is the current status of trial NCT05629052?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2023-04-12. Estimated completion is 2028-04.
What conditions does trial NCT05629052 study?
This clinical trial studies the following conditions: Chronic Thromboembolic Pulmonary Hypertension, CTEPH.
What interventions are being tested in trial NCT05629052?
The interventions under investigation include: Pulmonary endarterectomy (PROCEDURE), Balloon pulmonary angioplasty (PROCEDURE), Pulmonary hypertension (PH)-specific medication (DRUG).
Who is sponsoring clinical trial NCT05629052?
This trial is sponsored by International CTEPH Association, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05629052 being conducted?
This trial has 20 study locations across California, Illinois, North Carolina, Texas, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Thromboembolic Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Pulmonary Hypertension Biorepository and Registry
RECRUITING
-
Chronic Thromboembolic Disease Registry
RECRUITING
-
Pulmonary Hypertension Association Registry
RECRUITING
-
Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients
COMPLETED · NA
-
RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.